Indication

MLH1

1 clinical trial

1 drug

Clinical trial

A Phase II Study of PD-1 Inhibition for the Prevention of Colon Adenomas in Patients With Lynch Syndrome and a History of Partial Colectomy

Status: Terminated, Estimated PCD: 2021-01-25

Drug